Lucid Historical Balance Sheet

LUCD Stock

USD 0.79 0.02 2.60%

Trend analysis of Lucid Diagnostics balance sheet accounts such as Accounts Payable of 1.3 M provides information on Lucid Diagnostics' total assets, liabilities, and equity, which is the actual value of Lucid Diagnostics to its prevalent stockholders. By breaking down trends over time using Lucid Diagnostics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Lucid Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Lucid Diagnostics is a good buy for the upcoming year.

Lucid Diagnostics Inventory

274,520

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lucid Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.

About Lucid Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Lucid Diagnostics at a specified time, usually calculated after every quarter, six months, or one year. Lucid Diagnostics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Lucid Diagnostics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Lucid currently owns. An asset can also be divided into two categories, current and non-current.

Lucid Diagnostics Balance Sheet Chart

At present, Lucid Diagnostics' Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 1.3 M, whereas Total Current Assets are forecasted to decline to about 19.4 M.

Total Current Liabilities Retained Earnings Accounts Payable Total Current Assets Net Debt Short Term Investments

Add Fundamental

Total Current Liabilities

Total Current Liabilities is an item on Lucid Diagnostics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Lucid Diagnostics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Accounts Payable

An accounting item on the balance sheet that represents Lucid Diagnostics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Lucid Diagnostics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Short Term Investments

Short Term Investments is an item under the current assets section of Lucid Diagnostics balance sheet. It contains any investments Lucid Diagnostics undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Lucid Diagnostics can easily liquidate in the marketplace.

Most accounts from Lucid Diagnostics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Lucid Diagnostics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lucid Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.At present, Lucid Diagnostics' Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 1.3 M, whereas Total Current Assets are forecasted to decline to about 19.4 M.

	2023	2024 (projected)
Other Liabilities	324.4K	288.3K
Total Current Liabilities	29.4M	30.9M

Other Liab Total Current Liabilities

Lucid Diagnostics balance sheet Correlations

	Total Current Liabilities	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Total Current Assets	Common Stock	Total Assets	Other Current Liab	Total Stockholder Equity	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Capital Stock	Net Working Capital	Net Receivables
Total Current Liabilities		-0.87	0.6	-0.89	0.65	0.37	0.67	0.44	0.78	-0.01	-0.03	0.37	0.57	0.79	-0.72	0.37	0.83	0.78	-0.07	0.66	0.91	0.98	-0.1	0.91	-0.1	0.24
Other Liab	-0.87		-0.68	0.82	-0.33	-0.28	-0.48	-0.36	-0.48	0.06	-0.05	-0.31	-0.41	-0.6	0.84	-0.31	-0.87	-0.72	0.1	-0.51	-0.95	-0.91	0.15	-0.95	0.14	-0.21
Net Tangible Assets	0.6	-0.68		-0.74	-0.08	-0.03	0.45	0.09	0.41	-0.24	0.31	-0.01	0.71	0.73	-0.49	-0.01	0.76	0.59	-0.55	0.28	0.71	0.69	-0.3	0.71	-0.35	-0.27
Retained Earnings	-0.89	0.82	-0.74		-0.5	-0.58	-0.88	-0.66	-0.54	-0.27	0.26	-0.58	-0.83	-0.94	0.58	-0.58	-0.73	-0.96	-0.06	-0.82	-0.88	-0.87	-0.18	-0.88	-0.16	-0.37
Accounts Payable	0.65	-0.33	-0.08	-0.5		0.56	0.58	0.57	0.62	0.34	-0.45	0.55	0.36	0.51	-0.11	0.55	0.16	0.52	0.38	0.6	0.34	0.52	0.31	0.33	0.3	0.5
Total Current Assets	0.37	-0.28	-0.03	-0.58	0.56		0.82	0.99	-0.05	0.92	-0.93	1.0	0.53	0.52	-0.08	1.0	-0.01	0.77	0.83	0.92	0.31	0.24	0.88	0.31	0.88	0.94
Common Stock	0.67	-0.48	0.45	-0.88	0.58	0.82		0.88	0.33	0.63	-0.62	0.81	0.88	0.9	-0.23	0.81	0.36	0.94	0.39	0.94	0.58	0.57	0.57	0.58	0.54	0.61
Total Assets	0.44	-0.36	0.09	-0.66	0.57	0.99	0.88		0.0	0.89	-0.89	0.99	0.62	0.61	-0.12	0.99	0.07	0.84	0.76	0.94	0.38	0.32	0.84	0.38	0.84	0.9
Other Current Liab	0.78	-0.48	0.41	-0.54	0.62	-0.05	0.33	0.0		-0.39	0.31	-0.07	0.33	0.58	-0.48	-0.07	0.68	0.34	-0.36	0.27	0.6	0.79	-0.44	0.6	-0.45	-0.17
Total Stockholder Equity	-0.01	0.06	-0.24	-0.27	0.34	0.92	0.63	0.89	-0.39		-0.99	0.92	0.39	0.27	0.26	0.92	-0.38	0.53	0.89	0.7	-0.06	-0.15	1.0	-0.06	0.99	0.89
Net Debt	-0.03	-0.05	0.31	0.26	-0.45	-0.93	-0.62	-0.89	0.31	-0.99		-0.93	-0.33	-0.25	-0.23	-0.93	0.37	-0.51	-0.93	-0.72	0.05	0.11	-0.98	0.05	-0.99	-0.92
Cash	0.37	-0.31	-0.01	-0.58	0.55	1.0	0.81	0.99	-0.07	0.92	-0.93		0.52	0.51	-0.1	1.0	0.0	0.78	0.83	0.91	0.33	0.25	0.88	0.32	0.88	0.95
Non Current Assets Total	0.57	-0.41	0.71	-0.83	0.36	0.53	0.88	0.62	0.33	0.39	-0.33	0.52		0.94	-0.07	0.52	0.35	0.84	0.0	0.69	0.49	0.52	0.34	0.49	0.28	0.22
Non Currrent Assets Other	0.79	-0.6	0.73	-0.94	0.51	0.52	0.9	0.61	0.58	0.27	-0.25	0.51	0.94		-0.33	0.51	0.58	0.9	-0.02	0.77	0.7	0.75	0.2	0.7	0.16	0.25
Other Assets	-0.72	0.84	-0.49	0.58	-0.11	-0.08	-0.23	-0.12	-0.48	0.26	-0.23	-0.1	-0.07	-0.33		-0.1	-0.91	-0.44	0.13	-0.36	-0.89	-0.8	0.34	-0.9	0.3	-0.13
Cash And Short Term Investments	0.37	-0.31	-0.01	-0.58	0.55	1.0	0.81	0.99	-0.07	0.92	-0.93	1.0	0.52	0.51	-0.1		0.0	0.78	0.83	0.91	0.33	0.25	0.88	0.32	0.88	0.95
Common Stock Shares Outstanding	0.83	-0.87	0.76	-0.73	0.16	-0.01	0.36	0.07	0.68	-0.38	0.37	0.0	0.35	0.58	-0.91	0.0		0.54	-0.39	0.35	0.94	0.92	-0.46	0.94	-0.45	-0.1
Short Term Investments	0.78	-0.72	0.59	-0.96	0.52	0.77	0.94	0.84	0.34	0.53	-0.51	0.78	0.84	0.9	-0.44	0.78	0.54		0.31	0.92	0.76	0.72	0.45	0.76	0.43	0.58
Non Current Liabilities Total	-0.07	0.1	-0.55	-0.06	0.38	0.83	0.39	0.76	-0.36	0.89	-0.93	0.83	0.0	-0.02	0.13	0.83	-0.39	0.31		0.59	-0.1	-0.19	0.89	-0.1	0.92	0.94
Other Current Assets	0.66	-0.51	0.28	-0.82	0.6	0.92	0.94	0.94	0.27	0.7	-0.72	0.91	0.69	0.77	-0.36	0.91	0.35	0.92	0.59		0.62	0.56	0.64	0.61	0.64	0.8
Other Stockholder Equity	0.91	-0.95	0.71	-0.88	0.34	0.31	0.58	0.38	0.6	-0.06	0.05	0.33	0.49	0.7	-0.89	0.33	0.94	0.76	-0.1	0.62		0.95	-0.15	1.0	-0.14	0.22
Total Liab	0.98	-0.91	0.69	-0.87	0.52	0.24	0.57	0.32	0.79	-0.15	0.11	0.25	0.52	0.75	-0.8	0.25	0.92	0.72	-0.19	0.56	0.95		-0.24	0.95	-0.24	0.12
Net Invested Capital	-0.1	0.15	-0.3	-0.18	0.31	0.88	0.57	0.84	-0.44	1.0	-0.98	0.88	0.34	0.2	0.34	0.88	-0.46	0.45	0.89	0.64	-0.15	-0.24		-0.16	1.0	0.86
Capital Stock	0.91	-0.95	0.71	-0.88	0.33	0.31	0.58	0.38	0.6	-0.06	0.05	0.32	0.49	0.7	-0.9	0.32	0.94	0.76	-0.1	0.61	1.0	0.95	-0.16		-0.14	0.22
Net Working Capital	-0.1	0.14	-0.35	-0.16	0.3	0.88	0.54	0.84	-0.45	0.99	-0.99	0.88	0.28	0.16	0.3	0.88	-0.45	0.43	0.92	0.64	-0.14	-0.24	1.0	-0.14		0.89
Net Receivables	0.24	-0.21	-0.27	-0.37	0.5	0.94	0.61	0.9	-0.17	0.89	-0.92	0.95	0.22	0.25	-0.13	0.95	-0.1	0.58	0.94	0.8	0.22	0.12	0.86	0.22	0.89

Click cells to compare fundamentals

Lucid Diagnostics Account Relationship Matchups

Lucid Diagnostics balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Current Liabilities	6.3M	15.7M	4.3M	8.4M	29.4M	30.9M
Net Tangible Assets	(5.3M)	(13.5M)	(24.1M)	19.6M	22.5M	23.7M
Retained Earnings	(5.5M)	(13.8M)	(41.9M)	(98.1M)	(150.7M)	(143.2M)
Accounts Payable	799.1K	2.1M	1.5M	1.1M	1.1M	1.3M
Total Current Assets	390.9K	1.4M	57.3M	24.4M	22.1M	19.4M
Common Stock	14.1K	14.1K	35K	41K	42K	28.6K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Lucid Diagnostics is a strong investment it is important to analyze Lucid Diagnostics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Lucid Diagnostics' future performance. For an informed investment choice regarding Lucid Stock, refer to the following important reports:

How To Invest In Lucid

Details

Is Lucid Stock a good investment?

Details

What is Lucid Diagnostics' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.

You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lucid Diagnostics. If investors know Lucid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lucid Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.12)

Revenue Per Share

0.09

Quarterly Revenue Growth

0.497

Return On Assets

(1.01)

Return On Equity

(10.08)

The market value of Lucid Diagnostics is measured differently than its book value, which is the value of Lucid that is recorded on the company's balance sheet. Investors also form their own opinion of Lucid Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Lucid Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lucid Diagnostics' market value can be influenced by many factors that don't directly affect Lucid Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Lucid Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lucid Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lucid Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Lucid Historical Balance Sheet

Lucid Diagnostics Inventory

274,520

About Lucid Balance Sheet Analysis

Lucid Diagnostics Balance Sheet Chart

Total Current Liabilities

Retained Earnings

Accounts Payable

Total Current Assets

Net Debt

Short Term Investments

Lucid Diagnostics balance sheet Correlations

Lucid Diagnostics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Lucid Diagnostics balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Current Assets
Cash And Short Term Investments	+ 1.0	Total Current Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Capital Stock	+ 1.0	Other Stockholder Equity
Net Working Capital	+ 1.0	Net Invested Capital

Net Working Capital	- 0.99	Net Debt
Net Debt	- 0.99	Total Stockholder Equity
Net Invested Capital	- 0.98	Net Debt
Short Term Investments	- 0.96	Retained Earnings
Capital Stock	- 0.95	Other Liab
Other Stockholder Equity	- 0.95	Other Liab